Published date: 29 June 2021

Last edited date: 29 June 2021

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 22 July 2021, 5pm

Contract summary

Industry

  • Laboratory services - 71900000

Location of contract

SE5

Value of contract

£600,000 to £1,000,000

Procurement reference

KCL-00001335

Published date

29 June 2021

Closing date

22 July 2021

Closing time

5pm

Contract start date

1 September 2021

Contract end date

2 September 2024

Contract type

Service contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

CANTOP-RCT is a non-commercial, UK multi-centre, pragmatic, parallel group, randomised, double-blind, placebo-controlled clinical trial of cannabidiol (CBD) as a treatment in early psychosis.

The primary objective of this trial is to test whether treatment with CBD improves psychotic symptoms when added to Treatment as Usual (TAU) in Clinical High Risk (CHR) patients.

Patients will be randomised in a 1:1 ratio to either TAU + Cannabidiol or TAU + Placebo. The sample size is 300 patients (n=150 per arm).

Patient recruitment will take place over 3 years. The total duration from first patient visit, to last patient visit, is anticipated to be 42 months.

The trial is co-sponsored by King's College London and South London & Maudsley NHS Foundation Trust and is funded by the National Institute for Health Research (NIHR) Efficacy and Mechanism Evaluation (EME) programme.

Service providers are invited to tender for the manufacture of the investigational medicinal products (including procurement of GMP grade CBD), complete associated stability and QC validation/testing, QP release, and store and distribute the IMP to UK trial sites.

In order to compliantly participate in the tender process, all bidders are expected to fulfill the scope and specification requirements.

More information

Links

Additional text

Is a Recurrent Procurement Type? : No

About the buyer

Contact name

Darran Whatley

Address

Centre for Global Mental Health |
Health Service and Population Research Department
London
SE5
United Kingdom

Telephone

02078488292

Email

darran.whatley@kcl.ac.uk